Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Clinical and morphologic efficacy of a complex antioxidant and energy correction therapy of different duration in brain infarction: results of a multicenter randomized trial].
Rumyantsevа SA, Kovalenko AL, Silinа EV, Stupin VA, Kabaeva EN, Chichanovskaya LV, Nazarov MV, Tsukurova LA, Burenichev DV, Golikov KV, Salnikov MV, Belova LA, Mashin VV, Mazina NK, Zhilina EA, Kolotik-Kameneva OY, Sherman MA. Rumyantsevа SA, et al. Among authors: chichanovskaya lv. Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(8):45-52. doi: 10.17116/jnevro20151158145-52. Zh Nevrol Psikhiatr Im S S Korsakova. 2015. PMID: 26356615 Clinical Trial. Russian.
[A comparative placebo-controlled clinical study on the efficacy and safety of interferon beta-1a for subcutaneous injections in patients with remitting multiple sclerosis: results of the first year of observations].
Boyko AN, Bosenko LP, Vasilovskiy VV, Volkova LI, Zakharova MN, Kotov SV, Lekomtseva EV, Negrich TI, Parshina EV, Patrusheva OP, Prokopenko SV, Sazonov DV, Timchenko PV, Trinitatskiy YV, Khabirov FA, Khavunka MY, Chichanovskaya LV, Sherman MA, Lin'kova YN, Zinkina-Orikhan AV, Tursunova KB. Boyko AN, et al. Among authors: chichanovskaya lv. Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(2. Vyp. 2):107-113. doi: 10.17116/jnevro201711722107-113. Zh Nevrol Psikhiatr Im S S Korsakova. 2017. PMID: 28617368 Clinical Trial. Russian.
[Efficacy, tolerability and safety of the treatment with teberif: the results of a 2-year randomized clinical trial of treatment naïve patients with remitting multiple sclerosis, who have not received DMT, after switching from other interferon β-1a].
Boyko AN, Bosenko LP, Vasilovskiy VV, Volkova LI, Zakharova MN, Kotov SV, Lekomtseva EV, Negrich TI, Parshina EV, Patrusheva OP, Prokopenko SV, Sazonov DV, Timchenko LV, Trinitatskiy YV, Khabirov FA, Khavunka MY, Chichanovskaya LV, Sherman MA, Ivanov RA, Lin'kova YN, Stukalina EY, Zinkina-Orikhan AV, Obukhova IG. Boyko AN, et al. Among authors: chichanovskaya lv. Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(2. Vyp. 2):73-85. doi: 10.17116/jnevro20191192273. Zh Nevrol Psikhiatr Im S S Korsakova. 2019. PMID: 31156245 Clinical Trial. Russian.